| 实施临床路径的宏观环境与微观管理的比较分析 |
| |
| 引用本文： | 曲豪,陶红兵,郭淑岩,陈璞,苗卫军.实施临床路径的宏观环境与微观管理的比较分析[J].中国医院管理,2009,29(8):11-12. |
| |
| 作者姓名： | 曲豪 陶红兵 郭淑岩 陈璞 苗卫军 |
| |
| 作者单位： | 华中科技大学同济医学院医药卫生管理学院,湖北,武汉,430030 |
| |
| 基金项目： | 卫生部医疗服务标准专业委员会研究项目 |
| |
| 摘 要： | 临床路径作为一种新型的病种管理模式，具有改善医疗服务质量，降低医疗服务费用，提高患者满意度，增强医院竞争力的作用。欧美等国家医院较早成功实施临床路径，而我国对临床路径的实施还刚刚起步。从宏观环境和微观管理2个层面．对影响临床路径开展的国内外因素进行比较分析，为临床路径的实施相关政策与制度的设计提供参考依据。
|
| 关 键 词： | 临床路径 病种管理 宏观环境 微观管理 |
Analysis of factors on the aspects of macro-environment and micro-management by comparison with other countries during the implementation of CP |
| |
| Institution: | QU Hao. TAO Hong-bing, GUO Shu-yan. et al (School of Medicine and Health Management , Tongji Medical Colllege , University of Science ＆ Technology of Huazhong, Wuhan, Hubei, 430030, China) |
| |
| Abstract: | Clinical Pathway （CP） could be considered as a new-style single-disease management model which could better medical quality , reduce medical fee, improve the degree of satisfaction and stengthen the competitive power .CP has being successfully implemented in America , European et al. early.Instead, it is a development stage in our country.Through macro-environment and micro-management , the paper analyzes the factors which are harmful to the development of CP in our country by comparison with other countries. On that basis, relative suggestions are raised and the future of CP is expected in China. |
| |
| Keywords: | clinical pathway single-disease management macro-environment micro-management |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
